Gene: TMEM167B
Official Full Name: transmembrane protein 167Bprovided by HGNC
Gene Summary: Involved in constitutive secretory pathway. Located in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13228 | TMEM167B Knockout cell line (HeLa) | Human | TMEM167B | 1:3~1:6 | Negative | Online Inquiry |
KO13229 | TMEM167B Knockout cell line (HCT 116) | Human | TMEM167B | 1:2~1:4 | Negative | Online Inquiry |
KO13230 | TMEM167B Knockout cell line (HEK293) | Human | TMEM167B | 1:3~1:6 | Negative | Online Inquiry |
KO13231 | TMEM167B Knockout cell line (A549) | Human | TMEM167B | 1:3~1:4 | Negative | Online Inquiry |
TMEM167B Gene Knockout Cell Lines are genetically engineered cell line models designed to facilitate the study of the TMEM167B gene's role in cellular processes. This product is the result of advanced CRISPR/Cas9 genome-editing technology that allows for the precise deletion of the TMEM167B gene, thereby enabling researchers to investigate its functional implications in cellular pathways and disease mechanisms.
The key function of TMEM167B knockout cell lines is to provide a platform for assessing the physiological impact of the absence of this gene. TMEM167B is associated with endosomal transport and lysosomal function, making these knockout models particularly valuable in understanding diseases linked to cellular trafficking and waste processing. By studying these cell lines, researchers can elucidate the gene's role in conditions like neurodegeneration and certain lysosomal storage disorders, which may pave the way for therapeutic interventions.
The scientific importance of TMEM167B knockout cell lines extends into both basic research and clinical applications. They can be employed in drug discovery processes to screen for potential compounds that modify the loss of function associated with TMEM167B deficiency, aiding the development of targeted therapies. Additionally, these models are crucial for the validation of genetic alterations observed in patient-derived samples, reinforcing their relevance in translational medicine.
One of the primary advantages of our TMEM167B knockout cell lines is their high specificity and efficiency, which surpass traditional knockout methods that might yield off-target effects or incomplete knockouts. Researchers can confidently use these cell lines to explore molecular pathways without the confounding variables often encountered in less precise methodologies. Furthermore, our comprehensive validation process ensures that the knockout is confirmed at both the genetic and protein levels, offering a reliable resource for accurate scientific inquiry.
Utilizing our TMEM167B Gene Knockout Cell Lines enhances the potential for groundbreaking discoveries and advances in understanding the biology behind critical diseases. This product is not just a tool for research; it signifies a leap towards innovative solutions in clinical settings. Backed by our company’s expertise in genetic engineering and commitment to providing high-quality biological products, we are dedicated to supporting researchers and clinicians in their quest for answers and advancements in the field of biotechnology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.